Exedy Corp
TSE:7278
Exedy Corp
TSE:7278
Price:
4 400
JPY
0.11%
Market Closed
Market Cap:
206.7B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Exedy Corp
4400
+5 (+0.11%)
| 52 Week Range |
2 550
4 730
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Exedy Corp
Balance Sheet
Balance Sheet Decomposition
Exedy Corp
Exedy Corp
| Current Assets | 162.2B |
| Cash & Short-Term Investments | 59.5B |
| Receivables | 54B |
| Other Current Assets | 48.7B |
| Non-Current Assets | 142.6B |
| Long-Term Investments | 7.8B |
| PP&E | 113.6B |
| Intangibles | 2.5B |
| Other Non-Current Assets | 18.7B |
| Current Liabilities | 52.9B |
| Accounts Payable | 36.9B |
| Accrued Liabilities | 2.6B |
| Other Current Liabilities | 13.4B |
| Non-Current Liabilities | 45.5B |
| Long-Term Debt | 22.1B |
| Other Non-Current Liabilities | 23.4B |
Balance Sheet
Exedy Corp
Exedy Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
33 808
|
31 975
|
42 392
|
44 698
|
45 413
|
45 416
|
51 567
|
55 407
|
59 538
|
74 043
|
|
| Cash Equivalents |
33 808
|
31 975
|
42 392
|
44 698
|
45 413
|
45 416
|
51 567
|
55 407
|
59 538
|
74 043
|
|
| Short-Term Investments |
0
|
0
|
1 023
|
1 642
|
1 465
|
1 846
|
1 777
|
1 974
|
2 155
|
2 105
|
|
| Total Receivables |
46 860
|
48 538
|
53 352
|
55 063
|
49 246
|
43 025
|
46 249
|
53 824
|
53 929
|
53 513
|
|
| Accounts Receivables |
46 529
|
48 307
|
52 020
|
53 573
|
47 608
|
41 609
|
45 643
|
52 985
|
53 572
|
53 044
|
|
| Other Receivables |
331
|
231
|
1 332
|
1 490
|
1 638
|
1 416
|
606
|
839
|
357
|
469
|
|
| Inventory |
31 678
|
30 278
|
31 433
|
32 892
|
33 611
|
33 499
|
34 399
|
41 726
|
44 198
|
44 278
|
|
| Other Current Assets |
10 595
|
10 629
|
4 026
|
3 907
|
2 817
|
2 344
|
2 703
|
2 261
|
3 634
|
2 950
|
|
| Total Current Assets |
122 941
|
121 420
|
132 226
|
138 202
|
132 552
|
126 130
|
136 695
|
155 192
|
163 454
|
176 889
|
|
| PP&E Net |
125 182
|
127 109
|
152 782
|
156 867
|
167 572
|
164 771
|
163 963
|
162 964
|
154 632
|
117 824
|
|
| PP&E Gross |
125 182
|
0
|
152 782
|
156 867
|
167 572
|
164 771
|
163 963
|
162 964
|
154 632
|
117 824
|
|
| Accumulated Depreciation |
0
|
0
|
192 455
|
202 941
|
215 670
|
218 136
|
239 607
|
256 799
|
281 460
|
341 305
|
|
| Intangible Assets |
3 695
|
3 759
|
3 283
|
3 036
|
3 112
|
2 669
|
2 120
|
2 274
|
1 955
|
1 428
|
|
| Goodwill |
0
|
0
|
526
|
528
|
528
|
528
|
528
|
528
|
984
|
984
|
|
| Note Receivable |
0
|
311
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
4 394
|
3 292
|
2 783
|
3 900
|
3 235
|
1 785
|
2 620
|
3 545
|
2 178
|
5 890
|
|
| Other Long-Term Assets |
4 414
|
3 382
|
4 489
|
4 852
|
4 976
|
5 136
|
6 815
|
8 282
|
8 672
|
18 920
|
|
| Other Assets |
0
|
0
|
526
|
528
|
528
|
528
|
528
|
528
|
984
|
984
|
|
| Total Assets |
260 972
N/A
|
259 273
-1%
|
296 089
+14%
|
307 385
+4%
|
311 975
+1%
|
301 019
-4%
|
312 741
+4%
|
332 785
+6%
|
331 875
0%
|
321 935
-3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
20 870
|
19 266
|
20 992
|
22 199
|
18 148
|
17 194
|
19 112
|
20 251
|
22 121
|
20 792
|
|
| Accrued Liabilities |
0
|
8 801
|
1 340
|
1 330
|
1 448
|
1 588
|
1 669
|
1 954
|
2 336
|
2 591
|
|
| Short-Term Debt |
5 142
|
5 423
|
3 534
|
3 681
|
2 967
|
2 237
|
2 234
|
2 518
|
4 570
|
3 828
|
|
| Current Portion of Long-Term Debt |
4 226
|
11 372
|
7 824
|
4 995
|
4 778
|
5 441
|
16 511
|
8 149
|
3 961
|
2 821
|
|
| Other Current Liabilities |
13 217
|
10 635
|
25 198
|
27 598
|
26 135
|
20 970
|
23 262
|
26 031
|
23 139
|
24 642
|
|
| Total Current Liabilities |
52 093
|
55 497
|
58 888
|
59 803
|
53 476
|
47 430
|
62 788
|
58 903
|
56 127
|
54 674
|
|
| Long-Term Debt |
29 102
|
21 673
|
34 770
|
35 052
|
38 124
|
37 393
|
24 703
|
28 479
|
26 459
|
24 835
|
|
| Deferred Income Tax |
3 691
|
2 403
|
3 402
|
2 204
|
1 368
|
159
|
887
|
1 245
|
697
|
30
|
|
| Minority Interest |
12 172
|
11 833
|
12 265
|
12 177
|
11 873
|
11 771
|
12 803
|
14 267
|
14 338
|
14 991
|
|
| Other Liabilities |
5 760
|
6 174
|
6 637
|
6 695
|
6 981
|
7 328
|
7 633
|
8 135
|
8 691
|
8 857
|
|
| Total Liabilities |
102 818
N/A
|
97 580
-5%
|
115 962
+19%
|
115 931
0%
|
111 822
-4%
|
104 081
-7%
|
108 814
+5%
|
111 029
+2%
|
106 312
-4%
|
103 387
-3%
|
|
| Equity | |||||||||||
| Common Stock |
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
8 284
|
|
| Retained Earnings |
131 668
|
140 318
|
166 046
|
177 808
|
186 206
|
191 319
|
192 878
|
202 160
|
202 808
|
188 129
|
|
| Additional Paid In Capital |
7 556
|
7 564
|
7 606
|
7 656
|
7 590
|
7 582
|
7 571
|
7 555
|
7 541
|
7 543
|
|
| Unrealized Security Profit/Loss |
1 587
|
920
|
1 165
|
1 330
|
863
|
290
|
287
|
250
|
815
|
1 091
|
|
| Treasury Stock |
1 480
|
1 444
|
1 400
|
1 367
|
1 144
|
3 859
|
3 822
|
3 768
|
3 709
|
3 682
|
|
| Other Equity |
10 539
|
6 051
|
1 574
|
2 257
|
1 646
|
6 098
|
1 271
|
7 275
|
11 454
|
19 365
|
|
| Total Equity |
158 154
N/A
|
161 693
+2%
|
180 127
+11%
|
191 454
+6%
|
200 153
+5%
|
196 938
-2%
|
203 927
+4%
|
221 756
+9%
|
225 563
+2%
|
218 548
-3%
|
|
| Total Liabilities & Equity |
260 972
N/A
|
259 273
-1%
|
296 089
+14%
|
307 385
+4%
|
311 975
+1%
|
301 019
-4%
|
312 741
+4%
|
332 785
+6%
|
331 875
0%
|
321 935
-3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
48
|
48
|
48
|
48
|
48
|
47
|
47
|
47
|
47
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
